Esperion Therapeutics (ESPR)
(Real Time Quote from BATS)
$2.13 USD
+0.04 (1.91%)
Updated Apr 24, 2024 10:10 AM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: BMO |
3/2024 | $-0.17 | 268.67% |
Earnings Summary
For their last quarter, Esperion Therapeutics (ESPR) reported earnings of -$0.50 per share, beating the Zacks Consensus Estimate of $-0.53 per share. This reflects a positive earnings surprise of 5.66%. Look out for ESPR's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 78.48%.
Earnings History
Price & Consensus
Zacks News for ESPR
Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
ESPR: What are Zacks experts saying now?
Zacks Private Portfolio Services